TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | 5 | -1 | 13 | 0 | 0 | 0 | 6 |
S | %wins | 0 | 100 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/24/21 12:08 | 2/23/21 | MEIP | Mei Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Driscoll Frederick W | CA | D | S | -101 | 4.03 | 0 | -25 | -40 | 38 | D | |||||||||||||||
8/13/20 16:31 | 8/11/20 | NK | Nantkwest, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Driscoll Frederick W | CA | D | S | -668 | 10.23 | 0 | -65 | -37 | 109 | D | |||||||||||||||
3/24/17 16:24 | 3/23/17 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Driscoll Frederick W | MA | O | CFO | S.d | -69 | 23.00 | 18 | -3 | -28 | 8 | D | 6 | 203 | 51 | 41 | 41 | 24 | 32 | 26 | 7 | -1 | -4 | |||
3/2/17 16:56 | 2/28/17 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Driscoll Frederick W | MA | O | CFO | S.d | -668 | 19.97 | 5 | -33 | -81 | 8 | D | -10 | 116 | 21 | 16 | 8 | 12 | 6 | 6 | 2 | -1 | 30 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |